Efficacy and Safety of Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials and Real-World Studies.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials and Real-World Studies.
Authors: Su HC; Department of Pharmacy, Chi Mei Medical Center, Tainan City, Taiwan., Lin HW; Department of General Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan., Tam KW; Cochrane Taiwan, Taipei Medical University, Taipei, Taiwan. kelvintam@tmu.edu.tw.; Division of General Surgery, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. kelvintam@tmu.edu.tw.; Division of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, 291, Zhongzheng Road, Zhonghe District, New Taipei City, 23561, Taiwan. kelvintam@tmu.edu.tw.
Source: Targeted oncology [Target Oncol] 2025 Jan; Vol. 20 (1), pp. 71-88. Date of Electronic Publication: 2024 Dec 10.
Publication Type: Journal Article; Systematic Review; Meta-Analysis
Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1776-260X
DOI:10.1007/s11523-024-01118-0